AZTherapies Doses First Patient in Phase 2a Study of ALZT-OP1a in Amyotrophic Lateral Sclerosis (ALS)
September 09, 2020 08:34 ET
|
AZTherapies, Inc.
BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the dosing of the first...
AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory Board
August 11, 2020 08:35 ET
|
AZTherapies, Inc.
BOSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the expansion of its...
AZTherapies Strengthens Board of Directors & Business Advisory Board with New Appointments
July 22, 2020 08:35 ET
|
AZTherapies, Inc.
Noah Gottdiener of Duff & Phelps and Thierry Porté of J.C. Flowers & Co. join BOD Retired Eli Lilly executive Joseph B. Kelley joins Business Advisory Board BOSTON, July 22, 2020 (GLOBE...
AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics
October 24, 2019 08:32 ET
|
AZTherapies, Inc.
Cutting-edge CAR-Treg technology could have broad application across common and rare neurodegenerative diseases Smith Founder and CEO Philip Ashton-Rickardt, Ph.D. joins as SVP of Immunology ...
INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimer’s Disease
February 11, 2019 08:00 ET
|
INmune Bio, Inc.
The Alzheimer’s Association awarded INmune Bio the Part the Cloud to RESCUE grant to target neuroinflammation in Alzheimer’s Disease LA JOLLA, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- INmune...
CreAgri Commitment to Neuroprotection Grows With Sponsorship to Major International Meeting About Prions and Alzheimer
May 23, 2014 06:30 ET
|
CreAgri, Inc.
HAYWARD, Calif., May 23, 2014 (GLOBE NEWSWIRE) -- Furthering its investment the area of neuroinflammation and neuroprotection CreAgri is focusing upon a number of close relationships with selected...